JinhongChang,Ju-TaoGuo, inAntiviral Research, 2015 Abstract Hepatitis B virus(HBV) has been considered to be a “stealth virus” that induces negligible innate immune responses during the early phase of infection. However, recent studies with newly developed experimental systems have revealed that vi...
Therefore, these mutations are likely to have important impacts on the clinical progression of the hepatitis B disease. In this review, the recent progress in research on HBV precore and basic core promoter mutations is discussed, including but not limited to insights into the related molecular ...
ANRS Research Centre in France is running IP-CURE-B proof of concept (PoC) Phase II clinical trial (NCT05045261), which is due to end on 30 June 2024. The aim of the study is to evaluate whether stopping nucleotide or nucleoside analogue (NUC) after selgantolimod (SLGN) treatment can...
Testing included quantitative hepatitis B surface antigen (HBsAg), antibodies to HBV antigens, quantitative HBV e antigen (HBeAg), HBV DNA, quantitative HBV core-related antigen (HBcrAg), the highly sensitive ARCHITECT HBsAg NEXT (HBsAgNx) assay, and a quantitative research assay for HBV pre...
Bibliographic Research on Hepatitis B Literatures Based on ISI Web of Knowledge基于Web of Knowledge的乙型肝炎文献计量研究乙型肝炎文献计量学科技期刊以ISI Web of Knowledge数据库为数据来源,通过文献计量分析法,对1997～2006年关于乙型肝炎的研究论文进行统计.对乙肝研究的期刊分布及其发文来源的机构和作者情况进行...
hepatitis. Thereafter, viral hepatitis type B became a driving force for the development of modern virus diagnostics and vaccines. This article will recapitulate the major advances in the field of hepatitis B research throughout the last 50 years and point out some perspectives for future research....
[Objective] To understand the situation of hepatitis B inoculation for those university freshman whose surface antigen and antibody of hepatitis B both were negative, in order to provide basic information for making prevention and control measures. [Methods] Tested both hepatitis B surface antigen and...
The paper announcing these results appeared in Nature a week after Murray submitted his second paper to that journal (Valenzuela et al., 1979). 3.3. The Institut Pasteur The third line of research into a recombinant hepatitis B vaccine took shape in the Institut Pasteur in France. The ...
Hepatitis B CARE: Clinical work, Advocacy, Research, and EducationTung T. Nguyen
Hepatitis B virus is a globally distributed pathogen and the history of HBV infection in humans predates 10000 years. However, long-term evolutionary history of HBV in Eastern Eurasia remains elusive. We present 34 ancient HBV genomes dating between appr